Stanford will rename campus spaces named for David Starr Jordan and relocate statue depicting Louis Agassiz
By Chris Peacock,
Stanford News
| 10. 07. 2020
Stanford will rename campus features named after David Starr Jordan and take actions to provide the public with a more complete view of his complex history, which includes not only his seminal leadership as the university’s founding president but also his parallel leadership in promoting eugenics.
The university will also relocate from the façade of Jordan Hall a statue of Jordan’s mentor, Louis Agassiz.
The decision follows a review conducted this summer by a committee of faculty, staff, students and alumni. The university’s Board of Trustees, acting on a recommendation by President Marc Tessier-Lavigne, approved these steps:
- Removing Jordan’s name from Jordan Hall, current home of the Department of Psychology; Jordan Quad and Jordan Modulars, near Panama Street and Campus Drive West; and Jordan Way in the Stanford Medical Center area;
- Relocating a statue of Agassiz from Jordan Hall to a location where it can be given appropriate context; and
- Developing an active effort to better explain the full range of Jordan’s legacy and contributions, beginning with an informational plaque in Jordan Hall and extending to additional efforts such as...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...